Program Book
Program Book
Program Book
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
control group received both an intravenous and oral placebo. Patients<br />
in both groups had access to standard medications for pain on a<br />
sliding scale as needed based on pain severity. Nurses were blinded<br />
to the patient’s group status. Patients were asked to score their pain<br />
experience using a visual analogue scale (VAS) three times per day<br />
during the inpatient admission while the plaque was in place as well as<br />
once the day after plaque removal and once at the 2-week postoperative<br />
visit. The nurse administering the steroid or placebo to the patient<br />
separately scored his/her perception of the patients’ pain using the<br />
Wong-Baker FACES scale.<br />
Results. Preliminary results indicate that there is a decreased pain in<br />
the patients in the steroid group both during plaque application and<br />
in the immediate post-operative period. Patient recruitment and data<br />
analysis is ongoing and full results will be presented at the ISOO.<br />
Conclusions. The use of intravenous and oral steroids should be<br />
considered both during the treatment period and post-operatively for<br />
plaque patients given the severe discomfort that many plaque patients<br />
experience.<br />
Financial disclosure. None<br />
1623 UM35<br />
UVEAL MELANOMA AMONG FINNISH CHILDREN AND<br />
ADOLESCENTS<br />
Rana’a Aljamal, Tero Kivelä (ranaa.aljamal@hus.fi)<br />
Departement of Ophthalmology, Ocular Oncology Service, Helsinki<br />
University Central Hospital,<br />
Purpose. To report uveal melanoma (UM) before the age of 25 years in<br />
Finland, a high incidence region for this cancer.<br />
Methods. A population-based study identified 24 patients (0.3%), aged<br />
between 13 and 24 years at diagnosis, treated in our hospital in 1963-<br />
2006. They were divided in two groups, the first consisted of 11 patients<br />
(9 females, 2 males) enucleated before 1997. The second was treated by<br />
irradiation after 1991, consisting of 11 patients (9 females, 2 males). Two<br />
other patients underwent local resection (male and female).<br />
Results. Tumour height was 4-11 mm (mean, 7) in the first and 4.4-13.7<br />
mm (mean, 8.5) in the second group and largest basal diameter ranged<br />
from 5-16 mm (mean, 10) and 2.5- 21 mm (mean, 15), respectively. Four<br />
patients died, 3 of UM (after 4, 12 and 21 years). All were female with<br />
spindle tumours. In the second group, 2 females died of UM (after 3<br />
and 4 years).<br />
Conclusions. UM is rarely seen among young children and adolescents.<br />
In this small series, females outnumbered males.<br />
Financial disclosure. None<br />
UVEAL MELANOMA<br />
Abstracts<br />
107<br />
406 UM 36<br />
RESULTS OF MELANOMA BRACHYTHERAPY IN AR-<br />
GENTINA<br />
Arturo Irarrazaval, Pablo Cazon (artuira@consultoresoftalmologicos.<br />
com)<br />
Consultores Oftalmologicos<br />
Purpose. To present our experience in 58 cases of choroidal melanoma<br />
treated with brachytherapy in Argentina.<br />
Methods. Retrospective study of the charts of 58 patients treated with<br />
brachytherapy.<br />
Results. There were, till today, 3 cases of metastases. We had 3<br />
recurrences, and could preserve the globe in 52 cases. 31 of our patients<br />
had a final visual acuity of 20/400 or better.<br />
Conclusions. Conservative treatment of melanoma, using brachytherapy,<br />
has good results in preserving the eye, without increase in mortality,<br />
and in more than half the patients, retaining useful vision.<br />
Financial disclosure. None